Unlock instant, AI-driven research and patent intelligence for your innovation.

Construction method and application of a chimeric antigen receptor carrier that enhances migration to tumor sites

A chimeric antigen receptor and carrier technology, applied in the field of tumor cell immunotherapy, can solve problems such as poor treatment effect of solid tumors

Active Publication Date: 2021-12-31
上海尚泰生物技术有限公司
View PDF14 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Although CAR-T and CAR-NK have achieved good therapeutic effects in hematological tumors, they are not effective in treating solid tumors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction method and application of a chimeric antigen receptor carrier that enhances migration to tumor sites
  • Construction method and application of a chimeric antigen receptor carrier that enhances migration to tumor sites
  • Construction method and application of a chimeric antigen receptor carrier that enhances migration to tumor sites

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0233] In a specific embodiment, the present invention provides a method for preparing engineered immune cells, comprising the following steps:

[0234] S1: Using CD3ζ as the intracellular signal segment of CAR, using the CD28 transmembrane region as the transmembrane region, the CD28 intracellular region as a co-stimulatory factor, and the human NKG2D extracellular binding region to recognize NKG2DL, constitute a chimera that specifically recognizes NKG2DL Antigen receptor, and artificially synthesize the corresponding nucleotide sequence: NKG2D-CD8α-CD28-CD3ζ, and connect CAR and CXCR3 nucleotide sequence through the nucleotide sequence of P2A to form a fusion gene: NKG2D-CD8α - CD28-CD3ζ-P2A-CXCR3.

[0235] S2: inserting the fusion gene fragment into the lentiviral expression plasmid to obtain the target plasmid. Packaged as a lentivirus carrying NKG2D-CD8α-CD28-CD3ζ-P2A-CXCR3.

[0236] S3: Adjust the NK-92 cell density to 1 × 10 5 Individual / ml, add virus concentrate by...

Embodiment 1

[0266] Example 1: Synthesis of CAR-NKG2D-P2A-CXCR3 vector

[0267] In this example, the extracellular segment of human NKG2D, the hinge region of human CD8α, the transmembrane region and intracellular region of human CD28, and the intracellular signal region of human CD3ζ were synthesized through the method of whole gene synthesis, which were connected in series with human CXCR3 through P2A The gene fragment constituted, and the two ends were respectively connected with Xba I and BamH I restriction sites.

Embodiment 2

[0268] Example 2: Construction of recombinant CAR-NKG2D-P2A-CXCR3 lentiviral vector

[0269]In this example, the CAR-NKG2D-P2A-CXCR3 (SEQ ID NO: 2) gene fragment obtained in Example 1 was cloned into the pCDH-CMV-MCS-EF1-CopGFP-T2A-Puro lentiviral vector, such as figure 1 shown. Use restriction endonucleases Xba I and BamH I to digest pCDH-CMV-MCS-EF1-CopGFP-T2A-Puro lentiviral vector and CAR-NKG2D-P2A-CXCR3 gene fragment respectively to obtain linearized pCDH -The CMV-MCS-EF1-CopGFP-T2A-Puro lentiviral vector and the digested CAR-NKG2D-P2A-CXCR3 gene fragment were incubated overnight at 16°C using the T4 DNA ligase system. Then the Stbl3 competent cells were transformed, the positive colonies were screened, and the plasmids of the positive colonies were extracted to obtain the CAR-NKG2D-P2A-CXCR3-pCDH expression vector.

[0270] 1. Double digested pCDH-CMV-MCS-EF1-CopGFP-T2A-Puro lentiviral vector

[0271] The double enzyme digestion reaction system is as follows (50μl): ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides CAR-NK92 cells expressing CXCR3, a preparation method and applications thereof. Specifically, the present invention provides an engineered immune cell expressing chimeric antigen receptor CAR and CXCR3 targeting NKG2DL. CXCR3 can not only help the migration of CAR-NK cells targeting NKG2DL to tumor cells, but also improve the killing activity of CAR-NK cells targeting NKG2DL on tumor cells. In particular, the NK cells expressing the CAR and CXCR3 containing the extracellular region of NKG2D in the present invention can effectively kill tumor cells, significantly improve the curative effect and reduce recurrence and side effects.

Description

technical field [0001] The invention relates to the field of tumor cell immunotherapy. Specifically, the present invention relates to CAR-NK92 cells expressing CXCR3, and their preparation methods and applications. Background technique [0002] Cellular immunotherapy is an emerging tumor treatment mode with significant curative effect, and it is a new type of autoimmune anti-cancer treatment. In recent years, chimeric antigen receptor T cell (CAR-T) therapy has achieved remarkable results in the treatment of leukemia. [0003] However, CAR-T also brings many side effects, such as cytokine storm and off-target effects. In addition, CAR-T is not effective against solid tumors. NK cells, as innate immune cells, can quickly exert cytotoxicity against tumor cells or virus-infected cells. NK has many immune advantages over T cells: NK cells are not restricted by HLA; NK cells can also bind to antibody Fc fragments through CD16 to induce specific killing of ADCC (antibody-depen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/10C12N15/867C07K19/00C12N15/62A61K35/17A61P35/00
Inventor 李晨蔚张坤
Owner 上海尚泰生物技术有限公司